|
Thursday, May 17, 2018, Washington, DC, 6:00 PM – 8:30 PM
Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice — A CNE Symposia Series Held During the 43rd Annual ONS CongressPART 4 — Non-Small Cell Lung Cancer
Location:
Marriott Marquis Washington, DC 901 Massachusetts Ave NW Washington, DC 20001 Hotel Phone: (202) 824-9200 Meeting Room: Independence A-E (Meeting Level 4)
Schedule (EST):
5:30 PM – 6:00 PM Registration and Dinner Buffet 6:00 PM – 8:30 PM Educational Program
Faculty:
Julie R Brahmer, MD Director, Thoracic Oncology Program Interim Director, Johns Hopkins Kimmel Cancer Center at Bayview Professor of Oncology Sidney Kimmel Comprehensive Cancer Center Johns Hopkins School of Medicine Baltimore, Maryland Jennifer Kapo, MD Chief, Palliative Care Service Yale New Haven Hospital Associate Professor of Medicine Department of Internal Medicine Yale University School of Medicine New Haven, Connecticut
Judy Pagtama, RN, MSN, FNP-C
Nurse Practitioner Stanford Cancer Institute Palo Alto, California Gregory J Riely, MD, PhD Associate Attending Memorial Sloan Kettering Cancer Center New York, New York Elizabeth S Waxman, RN, MSN, ANP-BC Nurse Practitioner in the Department of Thoracic/Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston, Texas Moderator: Neil Love, MD Research To Practice Miami, Florida Module 1: Optimal Tumor Testing Algorithms; Management of Non-Small Cell Lung Cancer (NSCLC) with EGFR-Activating Mutations DISCUSSION TOPICS
Module 2: Existing and Emerging Therapeutic Options for Patients with ALK- and ROS1-Positive Disease DISCUSSION TOPICS
Module 3: Other Potentially Targetable Tumor Mutations (BRAF V600E, HER2, RET, et cetera) DISCUSSION TOPICS
Module 4: Practical Integration of Anti-PD-1/PD-L1 Antibodies into Current Treatment Algorithms for Patients with Locally Advanced NSCLC DISCUSSION TOPICS
Module 5: Clinical Approach to Metastatic NSCLC without a Targetable Mutation DISCUSSION TOPICS
Special Session: Dr Kapo Using effective palliative care strategies to improve survival and other outcomes for patients with cancer Target Audience:
Research To Practice (RTP) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation. Credit Designation Statements: This educational activity for 2.5 contact hours is provided by RTP. This activity is awarded 2.5 ANCC pharmacotherapeutic contact hours. To obtain a certificate of completion and receive credit for this event, nurses must sign in at the registration desk upon arrival, attend the entire activity and return a completed Educational Assessment and Credit Form upon exiting the activity. Oncology Nursing Certification Corporation (ONCC)/Individual Learning Needs Assessment (ILNA) Certification Information: The program content has been reviewed by the ONCC and is acceptable for recertification points. Learners must apply for CNE credit to utilize this program for ONCC certification or renewal. http://www.ResearchToPractice.com/Meetings/ONS2018/ILNA Unlabeled/Unapproved Uses Notice: There is no implied or real endorsement of any product by RTP or the ANCC. Any off-label use as declared by the FDA will be identified. Content Validation and Disclosures: RTP is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CNE activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. RTP staff and external reviewers — The scientific staff, planners and managers for RTP have no relevant conflicts of interest to disclose. Supporters: This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Merck and Takeda Oncology. Marriott Marquis Washington, DC Meeting Room: The Marriott Marquis Washington, DC is the headquarters hotel for the 2018 ONS Congress and provides direct access to the Walter E Washington Convention Center via an underground concourse.
Thank you for your interest in our CNE symposia series. At this time, online preregistration is closed for PART 4 — Non Small Cell Lung Cancer. Onsite registration will be open starting at 5:15 PM (ET) on Thursday, May 17th. If you are interested in standing by for seating (day of the program), please visit our onsite registration desk located outside Independence A-E, Ballroom (Meeting Level 4) at the Marriott Marquis Washington, DC (901 Massachusetts Ave NW, Washington, DC 20001). You may arrive up to 45 minutes before the program start time and receive a standby ticket. If seats become available for the program, we will accept standby registration on a first come, first served basis. Please note, onsite registration does not guarantee participation in the session or meal service. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com or call (800) 233-6153. |